Intra-Cellular Therapies Inc (NASDAQ:ITCI)

Delayed Data
As of Nov 26
 -1.11 / -2.55%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Intra-Cellular Therapies Inc have a median target of 54.00, with a high estimate of 81.00 and a low estimate of 40.00. The median estimate represents a +27.27% increase from the last price of 42.43.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in Intra-Cellular Therapies Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -5.58%
Growthannually -6.76%


Growthquarterly 15.21%
Growthannually 266.42%
Key to the earnings and sales forecast charts.